These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 22258722)
1. Structural remodeling and mechanical function in heart failure. Leonard BL; Smaill BH; LeGrice IJ Microsc Microanal; 2012 Feb; 18(1):50-67. PubMed ID: 22258722 [TBL] [Abstract][Full Text] [Related]
2. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Westermann D; Lindner D; Kasner M; Zietsch C; Savvatis K; Escher F; von Schlippenbach J; Skurk C; Steendijk P; Riad A; Poller W; Schultheiss HP; Tschöpe C Circ Heart Fail; 2011 Jan; 4(1):44-52. PubMed ID: 21075869 [TBL] [Abstract][Full Text] [Related]
3. Cardiac remodeling and failure From molecules to man (Part II). Fedak PW; Verma S; Weisel RD; Li RK Cardiovasc Pathol; 2005; 14(2):49-60. PubMed ID: 15780796 [TBL] [Abstract][Full Text] [Related]
4. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress. Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284 [TBL] [Abstract][Full Text] [Related]
5. Changing the remodeling process in heart failure: basic mechanisms and laboratory results. Francis GS Curr Opin Cardiol; 1998 May; 13(3):156-61. PubMed ID: 9649937 [TBL] [Abstract][Full Text] [Related]
6. A look between the cardiomyocytes: the extracellular matrix in heart failure. Miner EC; Miller WL Mayo Clin Proc; 2006 Jan; 81(1):71-6. PubMed ID: 16438481 [TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix dynamics in heart failure: a prospect for gene therapy. Tyagi SC J Cell Biochem; 1998 Mar; 68(4):403-10. PubMed ID: 9493904 [TBL] [Abstract][Full Text] [Related]
8. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Creemers EE; Pinto YM Cardiovasc Res; 2011 Feb; 89(2):265-72. PubMed ID: 20880837 [TBL] [Abstract][Full Text] [Related]
10. Cardiac remodeling and failure: from molecules to man (Part III). Fedak PW; Verma S; Weisel RD; Skrtic M; Li RK Cardiovasc Pathol; 2005; 14(3):109-19. PubMed ID: 15914295 [TBL] [Abstract][Full Text] [Related]
11. Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts. Seeland U; Kouchi I; Zolk O; Itter G; Linz W; Böhm M J Mol Cell Cardiol; 2002 Feb; 34(2):151-63. PubMed ID: 11851355 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of diastolic dysfunction in heart failure. Borlaug BA; Kass DA Trends Cardiovasc Med; 2006 Nov; 16(8):273-9. PubMed ID: 17055383 [TBL] [Abstract][Full Text] [Related]
13. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload. Janicki JS; Brower GL; Gardner JD; Forman MF; Stewart JA; Murray DB; Chancey AL Cardiovasc Res; 2006 Feb; 69(3):657-65. PubMed ID: 16376324 [TBL] [Abstract][Full Text] [Related]
14. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure]. Yang YJ; Zhang X; Zhu WL; Huang Y Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324 [TBL] [Abstract][Full Text] [Related]